Kornelia Chrapkova (facilitator)

Affiliation: Institute for Clinical and Experimental Medicine 
                                                               
Country: Czech Republic

Conflict of interest: None

Inese Sviestina (facilitator)

Affiliation: Children Clinical University Hospital / University of Latvia

Country: Latvia

Conflict of interest: None

Ute Blassmann 

Affiliation: Heidelberg University Hospital                                                                     

Country: Germany

Conflict of interest: None

Peter Declercq

Affiliation: University Hospitals Leuven

Country: Belgium

Conflict of interest: None

Annette Schuermans

Affiliation: University Hospitals Leuven

Country: Belgium

Conflict of interest: None

Martin Hug

Affiliation: Insitute of Pharmaceutical Sciences, University of Freiburg

Country: Germany

Conflict of interest: None

Philipp Wohlfarth

Affiliation: Medical University of Vienna

Country: Austria

Conflict of interest: None

Tine Van Nieuwenhuyse

Affiliation: UZ Leuven

Country: Belgium

Conflict of interest: None

William Hope* 

Affiliation: University of Liverpool

Country: United Kingdom

Conflict of interest: William Hope holds or has recently held research grants with F2G, AiCuris, Astellas Pharma, Spero Therapeutics, Matinas Biosciences, Antabio, Amplyx, Allecra, Bugworks, NAEJA-RGM, AMR Centre, and Pfizer. He holds awards from the Medical Research Council, National Institute of Health Research, FDA and the European Commission. William Hope has received personal fees in his capacity as a consultant for F2G, Amplyx, Ausperix, Spero Therapeutics and BLC/TAZ. 

Isabel Spriet

Affiliation: UZ Leuven

Country: Belgium

Conflict of interest: None

Anouk Muller

Affiliation: HaaglandenMC, The Hague and ErasmusMC, Rotterdam

Country: The Netherlands

Conflict of interest: None